Document Information


PMID 18598679  (  )
Title The NADPH oxidase is involved in lipopolysaccharide-mediated motor neuron injury.
Abstract Recent evidence indicates that neuroinflammation is a key event in amyotrophic lateral sclerosis (ALS). However, the precise impact of inflammation on motor neurons remains elusive. By using organotypic spinal cord slice cultures, we demonstrate that exposure to lipopolysaccharide (LPS) led to the demise of motor neurons in a dose- and time- dependent manner, whereas interneurons were impaired relatively mildly. The ultrastructure of motor neurons showed extensive vacuolation and swollen mitochondria. Motor neurons lacked the expression of calretinin, and BAPTA-AM, an intracellular calcium chelator, ameliorated motor neuron injury, indicating that the low capacity of calcium buffering may partially account for the vulnerability of motor neurons. NADPH oxidase was activated upon LPS challenge, and apocynin, the selective inhibitor of this enzyme, prevented inflammation-mediated toxicity to motor neurons, suggesting that NADPH oxidase may play a critical role in motor neuron death caused by LPS-induced inflammation. Shijiazhuang, Hebei 05000, People's Republic of China.

NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.



Targets by SciMiner Summary

HUGO ID Symbol Target Name #Occur ActualStr
14874NOX5NADPH oxidase, EF-hand calcium binding domain 524nadph oxidase |
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)12p47 |
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)10Nox2 | gp91 phox |
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))8SOD1 |
4141GAPDHglyceraldehyde-3-phosphate dehydrogenase4GAPDH |
1473CANXcalnexin2calnexin |
30306PHB2prohibitin 22p22 | BAP |
7661NCF2neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2)1p67 phox |
15531EBNA1BP2EBNA1 binding protein 21p40 |
9801RAC1ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)1rac1 |
11850TLR4toll-like receptor 41TLR4 |
7889NOX1NADPH oxidase 11Nox1 |
11848TLR2toll-like receptor 21TLR2 |
10940SLC1A2solute carrier family 1 (glial high affinity glutamate transporter), member 21EAAT2 |
7562MYD88myeloid differentiation primary response gene (88)1MyD88 |
2577CYBAcytochrome b-245, alpha polypeptide1p22 phox |

 


Targets by SciMiner Full list

HUGO ID Symbol Name ActualStr Score FlankingText
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8Expression of mutant human SOD1 selectively in neurons failed to cause ALS-like disease in mice
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8Moreover selective reduction of mutant SOD1 levels in microglia extended survival of transgenic SOD1 G37R mice
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8of mutant SOD1 levels in microglia extended survival of transgenic SOD1 G37R mice ( Boill_amp_#xe9 e et al. 2006
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8In addition in the mutant SOD1 G93A transgenic mice inflammatory responses are present before any evidence
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8Nguyen et al (2004) 2004 triggered the innate immunity of SOD1 G37R transgenic mice with systemic administration of lipopolysaccharide (LPS), LPS
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9NADPH oxidase subunits (gp91 gp91 phox p47 phox and IL-1_amp_#x3b2 mRNA expression were evaluated by semiquantitative RT-PCR
4141GAPDHglyceraldehyde-3-phosphate dehydrogenaseGAPDH1.5and IL-1_amp_#x3b2 mRNA expression were evaluated by semiquantitative RT-PCR using GAPDH gene as internal standard
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9nonfat dry milk before being probed with primary antibodies to p47 phox (1:200, 1 200 Santa Cruz CA
30306PHB2prohibitin 2BAP0.530LPS-treated slices 30LPS 30_amp_#xa0;_amp_#x3bc;g/ml 30_amp_#xa0 _amp_#x3bc g ml LPS 10_amp_#xa0 BAP LPS 10_amp_#xa0 _amp_#x3bc M BAPTA-AM 30_amp_#xa0;_amp_#x3bc;g/ml 30_amp_#xa0 _amp_#x3bc g ml
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9Changes in the message level of IL-1_amp_#x3b2 gp91 phox and p47 phox in slice cultures after LPS exposure
4141GAPDHglyceraldehyde-3-phosphate dehydrogenaseGAPDH1.5B Ratio of PCR product from IL-1_amp_#x3b2 to that of GAPDH mRNA
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9C Representative bands of NADPH oxidase subunits gp91 phox and p47 phox mRNA expression in slices treated with medium alone or
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9(D) D Ratio of PCR product from gp91 phox and p47 phox to that of GAPDH mRNA
4141GAPDHglyceraldehyde-3-phosphate dehydrogenaseGAPDH1.5product from gp91 phox and p47 phox to that of GAPDH mRNA
4141GAPDHglyceraldehyde-3-phosphate dehydrogenaseGAPDH1.5GAPDH was used as an internal control
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9Immunoblots (A) A for p47 phox using cytosolic and membranous extracts prepared from the slice
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9the message levels of NADPH oxidase subunits gp91 phox and p47 phox
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9There was no notable difference in the p47 phox message level between the control and LPS groups (
30306PHB2prohibitin 2p220.5resting cells composed of two membrane-bound components gp91 phox and p22 phox and several cytosolic components including p47 phox p40 phox
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9gp91 phox and p22 phox and several cytosolic components including p47 phox p40 phox p67 phox and rac1/2 rac1 2 (
15531EBNA1BP2EBNA1 binding protein 2p400.3and p22 phox and several cytosolic components including p47 phox p40 phox p67 phox and rac1/2 rac1 2 ( Babior et
9801RAC1ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)rac10.0components including p47 phox p40 phox p67 phox and rac1/2 rac1 2 ( Babior et al. 2002
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9Two weeks after application of LPS cytosolic subunit p47 phox translocated to the plasma membrane ( Fig 6 A
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9oxidase inhibitor apocynin which significantly reduced LPS-induced PHOX cytosolic subunit p47 phox translocation to the cell membrane ( Fig 6 A
11848TLR2toll-like receptor 2TLR20.6It has been reported that the expression of TLR2 was upregulated in the spinal cord of mutant SOD1 G37R
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8of TLR2 was upregulated in the spinal cord of mutant SOD1 G37R transgenic mice ( Nguyen et al. 2004 and MyD88
7562MYD88myeloid differentiation primary response gene (88)MyD880.3SOD1 G37R transgenic mice ( Nguyen et al. 2004 and MyD88 _amp_#x2212;/_amp_#x2212; _amp_#x2212 _amp_#x2212 -SOD1 G37R chimeric mice ( Kang and
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8( Nguyen et al. 2004 and MyD88 _amp_#x2212;/_amp_#x2212; _amp_#x2212 _amp_#x2212 -SOD1 G37R chimeric mice ( Kang and Rivest 2007 making it
11850TLR4toll-like receptor 4TLR41.6Lehnardt et al. (2002) 2002 verified that microglia and its TLR4 is necessary for LPS-induced oligodendrocyte injury
11179SOD1superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult))SOD10.8is up-regulated in the spinal cords of ALS patients and SOD1 G93A transgenic mice ( Wu et al. 2006 and deletion
7889NOX1NADPH oxidase 1Nox10.9mice ( Wu et al. 2006 and deletion of either Nox1 or Nox2 gene significantly slowed disease progression and improved survival
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)Nox22.5Wu et al. 2006 and deletion of either Nox1 or Nox2 gene significantly slowed disease progression and improved survival of ALS
7660NCF1neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1)p470.9gp91 phox mRNA expression and the translocation of cytosolic component p47 phox to the membrane following LPS challenge
10940SLC1A2solute carrier family 1 (glial high affinity glutamate transporter), member 2EAAT21.0Corroborating this view are the elevated levels of EAAT2 after exposure to LPS ( Persson et al. 2005 and
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase was activated upon lps challenge and apocynin the selective inhibitor of this enzyme prevented inflammation mediated toxicity to motor neurons suggesting that nadph oxidase may play a critical role in motor neuron death caused by lps induced inflammation.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase acting as the functional enzyme in the respiratory burst generates ros not as a byproduct but rather as the primary function of the enzyme system bedard and krause 2007 .
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0recent studies indicate that ros produced by nadph oxidase could promote neurodegeneration [block and hong 2005] and [li et al. 2005] but the role of nadph oxidase in als remains largely unexplored.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0to study the involvement of reactive oxygen species in inflammation induced effects nadph oxidase selective inhibitor apocynin 0.5 and 1_amp_#xa0;mm was coapplied with lps 30_amp_#xa0;_amp_#x3bc;g/ml for 2_amp_#xa0;weeks in the culture medium.
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0nadph oxidase subunits gp91 phox p47 phox and il 1_amp_#x3b2; mrna expression were evaluated by semiquantitative rt pcr using gapdh gene as internal standard.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase subunits gp91 phox p47 phox and il 1_amp_#x3b2; mrna expression were evaluated by semiquantitative rt pcr using gapdh gene as internal standard.
1473CANXcalnexincalnexin1.0bodies were applied and the bands of interest were detected using an odyssey infrared imaging system li cor lincoln nebraska . _amp_#x3b2; actin was used as internal standard of cytosolic protein and calnexin was used as internal standard of membrane protein.
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0fig. 5._amp_#xa0;changes in the message level of il 1_amp_#x3b2; gp91 phox and p47 phox in slice cultures after lps exposure.
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0 c representative bands of nadph oxidase subunits gp91 phox and p47 phox mrna expression in slices treated with medium alone or 30_amp_#xa0;_amp_#x3bc;g/ml lps for 2_amp_#xa0;weeks after 1_amp_#xa0;week in culture.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0 c representative bands of nadph oxidase subunits gp91 phox and p47 phox mrna expression in slices treated with medium alone or 30_amp_#xa0;_amp_#x3bc;g/ml lps for 2_amp_#xa0;weeks after 1_amp_#xa0;week in culture.
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0 d ratio of pcr product from gp91 phox and p47 phox to that of gapdh mrna.
1473CANXcalnexincalnexin1.0immunoblots a for p47 phox using cytosolic and membranous extracts prepared from the slice cultures. _amp_#x3b2; actin was used as internal standard of cytosolic protein and calnexin was used as internal standard of membrane protein.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase inhibitor apocynin prevented lps induced toxicity to motor neurons.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase and il 1_amp_#x3b2; mrna expression in spinal cord slices treated with lps
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0we also investigated the message levels of nadph oxidase subunits gp91 phox and p47 phox .
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0we also investigated the message levels of nadph oxidase subunits gp91 phox and p47 phox .
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0the mrna expression of gp91 phox in the slices treated with lps significantly increased compared to the controls figs 5 c and d .
2577CYBAcytochrome b-245, alpha polypeptidep22 phox1.0nadph oxidase also known as phagocytic oxidase phox is a dormant enzyme in resting cells composed of two membrane bound components gp91 phox and p22 phox and several cytosolic components including p47 phox p40 phox p67 phox and rac1/2 babior et al. 2002 .
7661NCF2neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2)p67 phox1.0lso known as phagocytic oxidase phox is a dormant enzyme in resting cells composed of two membrane bound components gp91 phox and p22 phox and several cytosolic components including p47 phox p40 phox p67 phox and rac1/2 babior et al. 2002 .
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0nadph oxidase also known as phagocytic oxidase phox is a dormant enzyme in resting cells composed of two membrane bound components gp91 phox and p22 phox and several cytosolic components including p47 phox p40 phox p67 phox and rac1/2 babior et al. 2002 .
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase also known as phagocytic oxidase phox is a dormant enzyme in resting cells composed of two membrane bound components gp91 phox and p22 phox and several cytosolic components including p47 phox p40 pho
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0gp91 phox is the catalytic core of the enzyme.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0due to its particular construction the functional change of nadph oxidase relies more importantly on subcellular distribution of cytosolic subunits.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0so we next investigated the function of nadph oxidase at protein level and whether it was required for neurotoxicity induced by lps mediated inflammation.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0we first determined whether nadph oxidase formed an assembled and activated enzyme complex upon lps challenge.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0two weeks after application of lps cytosolic subunit p47 phox translocated to the plasma membrane fig 6 a indicating that nadph oxidase became activated.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0next we examined the effect of nadph oxidase inhibitor apocynin which significantly reduced lps induced phox cytosolic subunit p47 phox translocation to the cell membrane fig 6 a .
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase is a membrane bound enzyme consisting of multiple subunits.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0in addition nadph oxidase derived ros can mediate proinflammatory gene expression and lead to the production of inflammatory cytokines qin et al. 2004 .
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase is therefore considered a key factor in oxidative stress and inflammatory processes both of which are implicated in the pathogenesis of als.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0we speculated that nadph oxidase might mediate the toxicity to motor neurons.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0this hypothesis is supported by two recent reports that nadph oxidase is up regulated in the spinal cords of als patients and sod1 g93a transgenic mice wu et al. 2006 and deletion of either nox1 or nox2 gene significantly slowed disease progression and improved surviva
2578CYBBcytochrome b-245, beta polypeptide (chronic granulomatous disease)gp91 phox1.0in the present study we found that nadph oxidase was activated as indicated by the up regulation of membranous subunit gp91 phox mrna expression and the translocation of cytosolic component p47 phox to the membrane following lps challenge.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0in the present study we found that nadph oxidase was activated as indicated by the up regulation of membranous subunit gp91 phox mrna expression and the translocation of cytosolic component p47 phox to the membrane following lps challenge.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0more importantly lps induced inflammation mediated toxicity to motor neurons was markedly ameliorated by the nadph oxidase inhibitor apocynin.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0these data provide evidence that nadph oxidase plays an important role in mediating motor neuron injury under inflammatory conditions.
14874NOX5NADPH oxidase, EF-hand calcium binding domain 5nadph oxidase1.0nadph oxidase contributes to the demise of motor neurons caused by lps induced inflammation.